| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9920 |
| Human Intestinal Absorption | HIA+ | 0.9974 |
| Caco-2 Permeability | Caco2+ | 0.8258 |
| P-glycoprotein Substrate | Substrate | 0.8930 |
| P-glycoprotein Inhibitor | Inhibitor | 0.5504 |
| Non-inhibitor | 0.8087 |
| Renal Organic Cation Transporter | Inhibitor | 0.5106 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4986 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7801 |
| CYP450 2D6 Substrate | Substrate | 0.8446 |
| CYP450 3A4 Substrate | Substrate | 0.7605 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8759 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8967 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.5571 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8942 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9146 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8846 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9229 |
| Non-inhibitor | 0.9436 |
| AMES Toxicity | Non AMES toxic | 0.8239 |
| Carcinogens | Non-carcinogens | 0.9655 |
| Fish Toxicity | High FHMT | 0.9655 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9523 |
| Honey Bee Toxicity | Low HBT | 0.5000 |
| Biodegradation | Not ready biodegradable | 0.9821 |
| Acute Oral Toxicity | III | 0.5323 |
| Carcinogenicity (Three-class) | Non-required | 0.6730 |